ABM Industries' ABM Respiratory Care Raises $14.8 Million for Innovative Respiratory Solutions

ABM Respiratory Care Secures $14.8 Million in Series B Financing to Advance Respiratory Solutions

ABM Respiratory Care (ABMRC), a prominent player in the medical technology sector focusing on airway clearance and ventilation solutions, announces the successful completion of its Series B financing round, raising $14.8 million. This funding not only surpasses the initial target of $12 million but also reflects strong investor confidence in the company’s vision and potential. The round is led by Peter Soderberg, ABMRC's Chairman and Managing Partner of Worthy Venture Resources, LLC, who significantly increases his investment, signaling robust belief in the company's capabilities. Additional support comes from Blue Wave Capital, LLC, among other investors committed to driving innovation in respiratory care.

The influx of capital will primarily facilitate the commercialization of ABMRC's innovative BiWaze® Clear system, a cutting-edge airway clearance device designed for both hospital and home environments. This compact and battery-operated system uniquely combines lung expansion, high-frequency oscillations, and aerosol delivery, aiming to revolutionize how patients experience respiratory therapy. CEO Greg Miller emphasizes that this funding will enhance access to their therapy platform, striving to improve the quality of life for individuals facing chronic breathing challenges. The BiWaze® Clear's design not only improves lung function by promoting mucus clearance but also optimizes aerosol deposition deep within the lungs, ultimately shortening therapy times and making the treatment more user-friendly.

As ABMRC looks ahead, the company is committed to developing intelligent and clinically differentiated respiratory care solutions that enhance patient outcomes on a global scale. With a focus on improving oxygen exchange, minimizing aerosol emissions, and fostering effective disease management, ABMRC sets its sights on making a significant impact in the respiratory care landscape. The successful funding round serves as a pivotal moment for ABMRC, enabling it to expand its reach and improve patient care through innovative technology.

In addition to the financing announcement, ABMRC's strategic direction highlights its dedication to advancing respiratory care innovation. The support from notable investors underscores the growing recognition of the need for effective respiratory solutions in an increasingly health-conscious society. With their sights firmly set on improving patient outcomes, ABMRC is poised to make a lasting difference in the lives of those struggling with respiratory issues.